PDC and cancer: SIRT3 participates in reprogramming of cancer cell metabolism by activating the ROS/HIF-1α pathway: SIRT3-mediated decrease in ROS level induces activation of oxygen-dependent prolyl hydroxylases (PHD) with subsequent degradation of hypoxia-induced factor 1-α (HIF-1α) [130,131].